Just in case you’ve been living under a rock this past year, you know the cost of epinephrine has skyrocketed to unbelievable prices.
Today, KALÉO announced the U.S. return of its AUVI-Q® auto-injector for life-threatening allergic reactions. Here’s the company press release and a round-up of articles online.
- Press Release: KALÉO announces 2017 U.S. Return of AUVI-Q® Auto-Injector for Life-Threatening Allergic Reactions
- Forbes Online: EpiPen Competitor Auvi-Q To Return To Market, Promising Lower Costs For Patients
- NY Times Online: An EpiPen Rival Is About to Return to the Shelves